Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Frank Griesinger, Prof. Dr.
Department of Hematology and Oncology, Oldenburg, Germany.
Study Chair - Johan Vansteenkiste, Prof. Dr.
Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium
Study Chair - Michael Kreuter, Dr.
Clinic for thoracic diseases at the University of Heidelberg, Germany
Study Chair - Michael Thomas, Prof. Dr.
Clinic for thoracic diseases at the University of Heidelberg, Germany
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ziekenhuis Oost Limburg
Genk, Belgium
- Department of Pulmonology (respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium.
Leuven, Belgium
- Helios-Klinikum Emil Von Behring
Berlin, Germany
- Klinikum Bremen-Ost
Bremen, Germany
- Westdeutsches Tumorzentrum
Essen, Germany
- Lungenzentrum Großhansdorf
Großhansdorf, Germany
- Department of Hematology and Oncology, University of Göttingen
Göttingen, Germany
- Clinic for Thoracic Diseases at the University of Heidelberg
Heidelberg, Germany
- Lungenklinik Hemer
Hemer, Germany
- Klinik Löwenstein
Löwenstein, Germany
- University of München
München, Germany
- Oldenburg Hospital
Oldenburg, Germany
- Dr. Horst Schmidt Klinik
Wiesbaden, Germany
- Centre Hospitalier Du Luxembourg
Luxembourg, Luxembourg
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2006
- Primary completion
- 14 Apr 2014
- Completion
- 14 Apr 2014
- Last update posted
- 19 Sept 2019
- Registered enrollment
- 132
- Registry id
- NCT00349089
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.